Senobari N, Nazari R, Ebrahimi P, Soleimani H, Taheri M, Hosseini K
Int J Emerg Med. 2024; 17(1):159.
PMID: 39433996
PMC: 11495085.
DOI: 10.1186/s12245-024-00750-x.
Chakrabartty A
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338387
PMC: 11435174.
DOI: 10.3390/ph17091225.
Leach B, Ferguson J, Morgan G, Sun X, Kroon G, Oyen D
J Mol Biol. 2024; 436(16):168673.
PMID: 38909653
PMC: 11410348.
DOI: 10.1016/j.jmb.2024.168673.
Leite J, Costa-Rodrigues D, Gales L
Molecules. 2024; 29(4).
PMID: 38398647
PMC: 10893244.
DOI: 10.3390/molecules29040895.
Kim B, Ko Y, Si J, Na J, Ortore G, Chiellini G
Comput Struct Biotechnol J. 2023; 21:4717-4728.
PMID: 37822560
PMC: 10562617.
DOI: 10.1016/j.csbj.2023.09.028.
Prion therapeutics: Lessons from the past.
Shim K, Sharma N, An S
Prion. 2022; 16(1):265-294.
PMID: 36515657
PMC: 9754114.
DOI: 10.1080/19336896.2022.2153551.
Recommendations for addressing the translational gap between experimental and clinical research on amyloid diseases.
Solomon M, Fodera V, Langkilde A, Elliott P, Tagliavini F, Forsyth T
J Transl Med. 2022; 20(1):213.
PMID: 35562704
PMC: 9102697.
DOI: 10.1186/s12967-022-03420-9.
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between and Mechanisms.
Faravelli G, Mondani V, Mangione P, Raimondi S, Marchese L, Lavatelli F
Front Mol Biosci. 2022; 9:830006.
PMID: 35237660
PMC: 8883118.
DOI: 10.3389/fmolb.2022.830006.
Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption.
Ferreira E, Almeida Z, Cruz P, Silva E Sousa M, Verissimo P, Brito R
Int J Mol Sci. 2022; 23(1).
PMID: 35008816
PMC: 8745744.
DOI: 10.3390/ijms23010391.
Molecular Mechanisms of Cardiac Amyloidosis.
Saito Y, Nakamura K, Ito H
Int J Mol Sci. 2022; 23(1).
PMID: 35008444
PMC: 8744761.
DOI: 10.3390/ijms23010025.
Exploring the Physiological Role of Transthyretin in Glucose Metabolism in the Liver.
Alemi M, Oliveira A, Tavares S, Vieira J, Alves M, Oliveira P
Int J Mol Sci. 2021; 22(11).
PMID: 34199897
PMC: 8200108.
DOI: 10.3390/ijms22116073.
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.
Brannagan 3rd T, Auer-Grumbach M, Berk J, Briani C, Bril V, Coelho T
Orphanet J Rare Dis. 2021; 16(1):204.
PMID: 33957949
PMC: 8100737.
DOI: 10.1186/s13023-021-01834-0.
Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.
Si J, Kim B, Kim J
Int J Mol Sci. 2021; 22(9).
PMID: 33922648
PMC: 8122960.
DOI: 10.3390/ijms22094429.
Nomenclature and diagnosis of amyloidosis from a historical perspective.
Aguirre M, Carretero M, Nucifora E, Posadas M
Rev Fac Cien Med Univ Nac Cordoba. 2021; 78(1):83-87.
PMID: 33787033
PMC: 8713366.
DOI: 10.31053/1853.0605.v78.n1.25202.
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness.
Nativi-Nicolau J, Karam C, Khella S, Maurer M
Heart Fail Rev. 2021; 27(3):785-793.
PMID: 33609196
PMC: 9033715.
DOI: 10.1007/s10741-021-10080-2.
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
Gertz M, Adams D, Ando Y, Beirao J, Bokhari S, Coelho T
BMC Fam Pract. 2020; 21(1):198.
PMID: 32967612
PMC: 7513485.
DOI: 10.1186/s12875-020-01252-4.
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature.
Dohrn M, Auer-Grumbach M, Baron R, Birklein F, Escolano-Lozano F, Geber C
J Neurol. 2020; 268(10):3610-3625.
PMID: 32500375
PMC: 8463516.
DOI: 10.1007/s00415-020-09962-6.
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases.
McAlary L, Plotkin S, Cashman N
CNS Drugs. 2019; 33(9):883-904.
PMID: 31414322
PMC: 6776490.
DOI: 10.1007/s40263-019-00657-9.
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy.
Buxbaum J
Degener Neurol Neuromuscul Dis. 2019; 2:165-173.
PMID: 30890886
PMC: 6065585.
DOI: 10.2147/DNND.S24624.
The Extracellular Protein, Transthyretin Is an Oxidative Stress Biomarker.
Sharma M, Khan S, Rahman S, Singh L
Front Physiol. 2019; 10:5.
PMID: 30733681
PMC: 6353848.
DOI: 10.3389/fphys.2019.00005.